Bill McGlashan is a founding Partner of TPG Growth – the growth equity and smaller buyout investment platform of TPG, the global private investment firm. With more than $3.5 billion under management, TPG Growth targets investments in technology, life sciences, renewables, industrials, and consumer companies utilizing growth equity, public equity and leveraged buyout structures. The firm invests globally, with a particular focus on the United States, Asia, and Latin America.
Prior to joining TPG in 2004, Bill McGlashan was the Chairman and CEO of Critical Path. He joined Critical Path in April of 2001 to undertake a major financial and operational restructuring of the company. Previously, Mr. McGlashan co-founded and served as Chief Executive Officer of Vectis Group, a venture corporation that capitalized and built companies in emerging markets, in partnership with leading U.S. technology businesses. Mr. McGlashan also co-founded and served as President of Pharmanex, Inc., a leading phyto-pharmaceutical and dietary supplement company with annual sales of approximately $1 billion globally. Prior to Pharmanex, Mr. McGlashan was a senior associate with Bain Capital and Information Partners.
Mr. McGlashan earned a B.A. with honors from Yale University and an M.B.A. from the Stanford Graduate School of Business. Bill is a member of Young Presidents' Organization in the San Francisco Barbary Coast chapter. He serves on the Boards of XOJET, AgraQuest, SuccessFactors, Elevance Renewable Sciences, and Schiff Nutrition International.
As part of his philanthropic and not-for-profit activities, he serves on the Advisory Council for the Yale School of Management, the board of the Bay Area Discovery Museum, and is active in the World Economic Forum.